Aridis Pharmaceuticals Inc
NASDAQ:ARDS

Watchlist Manager
Aridis Pharmaceuticals Inc Logo
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Watchlist
Price: 0.0625 USD 4.17% Market Closed
Updated: Jun 2, 2024

Aridis Pharmaceuticals Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aridis Pharmaceuticals Inc
Additional Paid In Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Additional Paid In Capital
$166.4m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Additional Paid In Capital
$20.7B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Additional Paid In Capital
$6.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
2%
Amgen Inc
NASDAQ:AMGN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Additional Paid In Capital
$7.3B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Additional Paid In Capital
$11.9B
CAGR 3-Years
20%
CAGR 5-Years
23%
CAGR 10-Years
18%

See Also

What is Aridis Pharmaceuticals Inc's Additional Paid In Capital?
Additional Paid In Capital
166.4m USD

Based on the financial report for Dec 31, 2022, Aridis Pharmaceuticals Inc's Additional Paid In Capital amounts to 166.4m USD.

What is Aridis Pharmaceuticals Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
17%

Over the last year, the Additional Paid In Capital growth was 9%. The average annual Additional Paid In Capital growth rates for Aridis Pharmaceuticals Inc have been 17% over the past three years .